Home  >  Products  >  ANXA1 (annexin A1 ) Blocking Peptide (the N terminal of ANXA1)(100ug)
ANXA1 (annexin A1 ) Blocking Peptide (the N terminal of ANXA1)(100ug)

ANXA1 (annexin A1 ) Blocking Peptide (the N terminal of ANXA1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ANXA1 Antibody (ARP36569_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP36569
Size: 100ug
Weight: 39kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Annexin I belongs to a family of Ca(2+)-dependent phospholipid binding proteins which have a molecular weight of approximately 35,000 to 40,000 and are preferentially located on the cytosolic face of the plasma membrane. Annexin I protein has an apparent relative molecular mass of 40 kDa, with phospholipase A2 inhibitory activity. Since phospholipase A2 is required for the biosynthesis of the potent mediators of inflammation, prostaglandins and leukotrienes, annexin I may have potential anti-inflammatory activity.
Alternative names: ANX1; LPC1
See Full Product Listings >